Structure and signalling in the IL-17 receptor superfamily
By S. Gaffen. Nature reviews. Immunology, 2009
1,388 citations recorded by the source corpus.
Interleukin-17A (IL-17A), the hallmark cytokine of the newly defined T helper 17 (TH17) cell subset, has important roles in protecting the host against extracellular pathogens, but also promotes inflammatory pathology in autoimmune disease. IL-17A and its receptor (IL-17RA) are the founding members of a newly described family of cytokines and receptors that have unique structural features which distinguish them from other cytokine families. Research defining the signal transduction pathways induced by IL-17R family cytokines has lagged behind that of other cytokine families, but studies in the past 2 years have begun to delineate unusual functional motifs and new proximal signalling mediators used by the IL-17R family to mediate downstream events.
Subfields: Cancer Research, Immunology, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/be05ab3452fa6eaca9a74a18bd4fd5e2b7d58e9b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Immunology
In Pathology and Forensic Medicine
Citations in the corpus
- STAT3 signaling in immunity (2016, background): “of immune effectors such as anti-microbial peptides, chemokines and granulopoietic cytokines [208,209].”
- Innate IL-17-producing cells: the sentinels of the immune system (2010, background): “We now have a fundamental understanding of how the IL-17R signalling pathway, through the adaptor molecule ACT1 (also known as CIKS) and the transcription factor nuclear factor- κB (NF-κB), induces downstream mediators, including IL-6, CXCL8 and CC-chemokine ligand 20 (CCL20”
- Inflammation, Immunity, and Hypertensive End-Organ Damage (2015, background): “These receptor chains are thought to heterodimerize on ligand binding and signal through the adaptor molecule Act1 and tumor necrosis receptor–associated factor-6, leading to nuclear factor kappa B, mitogen-activated protein kinase and CCAAT-enhancer–binding protein-δ activation.(35) Importantly, IL”
- Psoriasis Pathogenesis and Treatment (2019, background): “In nail psoriasis and psoriatic arthritis (PsA), an increased expression of TNF-α, NFκB, IL-6, and IL-8 in psoriasis-affected nails is consistent with the inflammatory markers found on lesional psoriatic skin [73].”
- Neutrophil cell surface receptors and their intracellular signal transduction pathways (2013, background): “Further details on TGFβ-receptor signal transduction [178,179] and IL17-mediated inflammatory responses and IL-17 receptor signaling [180–184] can be found in excellent recent reviews.”
- Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. (2012, neutral): “Oral or intramuscular glucocorticoids 5 (13) 4 (10) 3 (8) 4 (10) 5 (12) 16 (10)”
- IL-17 Signaling: The Yin and the Yang (2017, background): “IL-17 signaling does not activate the non-canonical NF-κB pathway [30].”